Form 4: Nexalin Technology Insider Transactions: Elson and Osser Report Changes in Beneficial Ownership

Sentiment:

SEC Form 4 Filing


Marilyn Elson and Leonard Osser, both directors and 10% owners of Nexalin Technology, report changes in their beneficial ownership of common stock.

Summary

  • Marilyn Elson, a director and 10% owner of Nexalin Technology, filed a Form 4 detailing changes in beneficial ownership.
  • The earliest transaction date reported is September 23, 2024.
  • Elson acquired 700,000 shares of common stock at $0.
  • Following the reported transaction, Elson beneficially owns 1,535,244 shares.
  • Leonard Osser, also a director and 10% owner, jointly filed the Form 4 with Elson.
  • The filing includes shares owned jointly with spouse Leonard Osser, for which Elson has shared voting and dispositive power.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard regulatory filing reporting insider transactions. The acquisition of shares could be seen as a positive signal, but without further context, it's difficult to assess the overall impact.

Industry Context

Form 4 filings are standard practice and provide transparency into the trading activities of company insiders, which can be closely monitored by investors for signals about the company's prospects.

Key Dates

DateDescription
09/23/2024Date of earliest transaction: Acquisition of 700,000 shares of common stock.
09/25/2024Date of signature for the Form 4 filing by Marilyn Elson and Leonard Osser.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.